Skip to main content
. 2016 Feb 2;2016:4692139. doi: 10.1155/2016/4692139

Figure 3.

Figure 3

Unadjusted post-TACE survival as a function of mRECIST dichotomized into responders (complete and partial response) and nonresponders (stable and progressive disease).